Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / MED BREAKTHGH
-
Total 13F shares
-
739,994
-
Share change
-
+42,322
-
Total reported value
-
$19,042,496
-
Put/Call ratio
-
48%
-
Price per share
-
$25.76
-
Number of holders
-
27
-
Value change
-
+$1,173,999
-
Number of buys
-
10
-
Number of sells
-
14
Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q1 2017
As of 31 Mar 2017,
ALPS ETF TR - MED BREAKTHGH (SBIO) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
739,994 shares.
The largest 10 holders included
RAYMOND JAMES & ASSOCIATES, UBS Group AG, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, LPL Financial LLC, GOLDMAN SACHS GROUP INC, CITADEL ADVISORS LLC, MORGAN STANLEY, JANE STREET GROUP, LLC, and ROYAL BANK OF CANADA.
This page lists
27
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.